33926 Efficacy of apremilast in mild to moderate psoriasis: Subgroup analysis stratified by baseline TSQM global satisfaction levels

Authors
Category Primary study
JournalJournal of the American Academy of Dermatology
Year 2022
This article has no abstract
Epistemonikos ID: a8f7dcdda30914cde1463eca4dc0f1f5d2aef84c
First added on: Feb 15, 2025